Clinical Scorecard: Evaluation of Factors Influencing Embryo Quality and Quantity in Endometriosis Patients Undergoing IVF/ICSI-ET

At a Glance

Key Highlights

• Endometriomas adversely affect oocyte yield and high-quality embryo rates.
• Anti-Müllerian Hormone level and Antral Follicle Count are strong predictors of oocyte yield.
• GnRH agonist pre-treatment may improve IVF/ICSI outcomes in endometriosis patients.

Guideline-Based Recommendations

Diagnosis

• Diagnosis of endometriosis should be confirmed via laparoscopic and/or hysteroscopic examination.

Management

• GnRH agonists may be considered for improving clinical pregnancy and live birth rates.

Monitoring & Follow-up

• Monitor ovarian reserve and response to stimulation in patients with endometriosis.

Risks

• Surgical intervention may adversely impact fertility; routine surgery is not recommended for asymptomatic patients.

Patient & Prescribing Data

Patients with endometriosis undergoing IVF/ICSI-ET

Personalized treatment strategies are essential for improving outcomes.

Clinical Best Practices

• Utilize predictive models to assess the likelihood of obtaining high-quality embryos.
• Consider the specific endometriosis phenotype when planning treatment.

References

• European Society of Human Reproduction and Embryology Guidelines
• Systematic Review by Salam et al.
• Meta-analysis by Cao et al.
• Meta-analysis by Georgiou et al.